Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
News + Filings
Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Fleming Harold Edward
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
06/09/2023
4
Fleming Harold Edward (Director) has filed a Form 4 on CRISPR Therapeutics AG
Txns:
Granted 13,000 options to buy @ $62.59, valued at $813.7k
06/10/2022
4
Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2021
4
Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2021
3
Form 3 - Initial statement of beneficial ownership of securities:
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy